))
EP65: Balancing the Blood Ledger - HemoSonics CEO on Innovation and Patient Care
Manage episode 426831908 series 3455377
Contenido proporcionado por Deborah S. Fell. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Deborah S. Fell o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
In this episode, Deborah welcomes Bob Roda, President and CEO of HemoSonics, about purpose-driven leadership in healthcare. Bob shares his journey from an economics major to a passionate advocate for improving patient care. He offers candid insights from his career at Johnson & Johnson to his current role in medical technology innovation.
Bob's story emphasizes continuous learning and embracing both successes and failures. He provides a fresh take on leadership, stressing the importance of the journey as much as the destination. Bob's commitment to making a meaningful impact in healthcare is evident throughout the conversation.
Join us for this engaging discussion on mentorship, the value of experience, and the challenges of driving change in clinical practice. Bob's insights offer valuable perspective for those at any stage of their career in, “Balancing the Blood Ledger: HemoSonics CEO on Innovation and Patient Care.”
About our guest:
Robert A. Roda (Bob) joined HemoSonics in February 2020 as the company’s President and CEO, bringing more than 25 years of global experience developing and commercializing innovative diagnostic and medical device products and services.
Most recently, Bob Roda served as President and CEO of Menarini Silicon Biosystems, Inc., a diagnostic and biotech company focused on the use of liquid biopsy and predictive diagnostic tests for the treatment of cancer patients. Prior to that position, he was Vice President and General Manager at Becton Dickinson, where he led the medical and procedural solutions business in the US. From 1998-2012, Bob held positions of increasing responsibility at Johnson & Johnson in both the medical device and diagnostic sectors, with his last role being worldwide VP Marketing in Immunohematology, Donor Screening, and Clinical Laboratories at Ortho Clinical Diagnostics, a J&J company. Bob earned a Bachelor of Arts in Economics from the University of Rhode Island and completed postgraduate coursework at Kellogg Graduate School of Management.
Links from this episode:
65 episodios
Compartir
